Immunomedics Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
186.83 M |
Public Float |
125.77 M |
Immunomedics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2 |
Market Cap |
$2.71 B |
Shares Outstanding |
191.54 M |
Public Float |
170.74 M |
Address |
300 The American Road Morris Plains New Jersey 07950 United States |
Employees | - |
Website | http://www.immunomedics.com |
Updated | 07/08/2019 |
Immunomedics, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. It operates through the United States, and Europe geographical segments. |